» Articles » PMID: 37396503

New Insight of Obesity-associated NAFLD: Dysregulated "crosstalk" Between Multi-organ and the Liver?

Overview
Journal Genes Dis
Date 2023 Jul 3
PMID 37396503
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity plays a crucial role in the development of non-alcoholic fatty liver disease (NAFLD). However, the underlying mechanism for the pathogenesis of obesity-associated NAFLD remains largely obscure. Although the "multiple hit" theory provides a more accurate explanation of NAFLD pathogenesis, it still cannot fully explain precisely how obesity causes NAFLD. The liver is the key integrator of the body's energy needs, receiving input from multiple metabolically active organs. Thus, recent studies have advocated the "multiple crosstalk" hypothesis, highlighting that obesity-related hepatic steatosis may be the result of dysregulated "crosstalk" among multiple extra-hepatic organs and the liver in obesity. A wide variety of circulating endocrine hormones work together to orchestrate this "crosstalk". Of note, with deepening understanding of the endocrine system, the perception of hormones has gradually risen from the narrow sense (i.e. traditional hormones) to the broad sense of hormones as organokines and exosomes. In this review, we focus on the perspective of organic endocrine hormones (organokines) and molecular endocrine hormones (exosomes), summarizing systematically how the two types of new hormones mediate the dialogue between extra-hepatic organs and liver in the pathogenesis of obesity-related NAFLD.

Citing Articles

Effects of Selected Food Additives on the Gut Microbiome and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Jarmakiewicz-Czaja S, Sokal-Dembowska A, Filip R Medicina (Kaunas). 2025; 61(2).

PMID: 40005309 PMC: 11857189. DOI: 10.3390/medicina61020192.


A Novel "Endocrine Hormone": The Diverse Role of Extracellular Vesicles in Multiorgan Insulin Resistance.

Xu F, Dou L, Yu D, Wu X, Liu L, Man Y Int J Med Sci. 2024; 21(11):2081-2093.

PMID: 39239539 PMC: 11373541. DOI: 10.7150/ijms.97217.


Huanglian-Hongqu herb pair improves nonalcoholic fatty liver disease via NF-κB/NLRP3 pathway in mice: network pharmacology, molecular docking and experimental validation.

Wang Z, Qiu H, Yang Y, Zhang Y, Mou T, Zhang X Hereditas. 2024; 161(1):12.

PMID: 38566171 PMC: 10988798. DOI: 10.1186/s41065-024-00316-0.


Glutamine prevents high-fat diet-induced hepatic lipid accumulation in mice by modulating lipolysis and oxidative stress.

Zhang Y, Wang Y, Liao X, Liu T, Yang F, Yang K Nutr Metab (Lond). 2024; 21(1):12.

PMID: 38459503 PMC: 10924388. DOI: 10.1186/s12986-024-00784-1.


A sport supplement candidate of Erigeron breviscapus extract regulates lipogenesis in vitro and in vivo.

Kim K, Baek S, Ko S, Moon S, Lee K, Ahn S Phys Act Nutr. 2024; 27(4):60-66.

PMID: 38297478 PMC: 10844721. DOI: 10.20463/pan.2023.0039.


References
1.
Polyzos S, Anastasilakis A, Efstathiadou Z, Makras P, Perakakis N, Kountouras J . Irisin in metabolic diseases. Endocrine. 2017; 59(2):260-274. DOI: 10.1007/s12020-017-1476-1. View

2.
Kurdiova T, Balaz M, Vician M, Maderova D, Vlcek M, Valkovic L . Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies. J Physiol. 2013; 592(5):1091-107. PMC: 3948565. DOI: 10.1113/jphysiol.2013.264655. View

3.
Zhang X, Ji X, Wang Q, Li J . New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Protein Cell. 2017; 9(2):164-177. PMC: 5818366. DOI: 10.1007/s13238-017-0436-0. View

4.
Du J, Zhang M, Lu J, Zhang X, Xiong Q, Xu Y . Osteocalcin improves nonalcoholic fatty liver disease in mice through activation of Nrf2 and inhibition of JNK. Endocrine. 2016; 53(3):701-9. DOI: 10.1007/s12020-016-0926-5. View

5.
Bertola A, Deveaux V, Bonnafous S, Rousseau D, Anty R, Wakkach A . Elevated expression of osteopontin may be related to adipose tissue macrophage accumulation and liver steatosis in morbid obesity. Diabetes. 2008; 58(1):125-33. PMC: 2606860. DOI: 10.2337/db08-0400. View